Research

Evidence-based, clinician-led

EtioLinksAI provides a mechanism-informed reasoning layer for conditions where symptoms and findings do not align — and early decisions determine long-term outcomes.

Explore research

A Broader Clinical Application

The pattern of pathway mismatch is not unique to chronic pain. Similar dynamics are seen in:

  • Functional gastrointestinal disorders
  • Pelvic pain
  • Migraine
  • Fatigue syndromes

EtioLinksAI provides a mechanism-informed reasoning layer for conditions where symptoms and findings do not align — and early decisions determine long-term outcomes.

Mechanism-Based Science

Modern pain science classifies persistent pain into three overlapping mechanisms — each with distinct drivers, evidence-aligned interventions, and predictable response profiles. The IASP framework1 recognises:

Nociceptive2

Tissue-driven pain from ongoing injury or inflammation. Responds to anti-inflammatory care and tissue-targeted intervention.

Neuropathic3

Nerve-driven pain from peripheral or central nervous system injury. Responds to neuropathic agents and targeted neuromodulation.

Nociplastic4

Pain that persists due to altered processing in the central nervous system, in the absence of clear tissue or nerve injury. Responds to mechanism-aligned reprocessing, paced activity, and behavioural pathways — not escalating tests or opioids.

When the underlying mechanism is misclassified, care drifts toward the wrong pathway — repeat imaging, escalating procedures, polypharmacy. Outcomes stall and costs compound.5 Mechanism-aligned care reverses this.

EtioLinksAI synthesises history, symptoms, examination findings, and treatment response into a structured mechanism profile. The reasoning is traceable at every step — every classification is grounded in the published mechanism literature, every recommendation is tied to evidence-aligned pathways, and every clinician retains full override authority.

References
  1. 1Treede RD, Rief W, Barke A, et al. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain. 2019;160(1):19–27. doi:10.1097/j.pain.0000000000001384
  2. 2Woolf CJ. What is this thing called pain? J Clin Invest. 2010;120(11):3742–3744. doi:10.1172/JCI45178
  3. 3Finnerup NB, Kuner R, Jensen TS. Neuropathic pain: from mechanisms to treatment. Physiol Rev. 2021;101(1):259–301. doi:10.1152/physrev.00045.2019
  4. 4Fitzcharles MA, Cohen SP, Clauw DJ, Littlejohn G, Usui C, Häuser W. Nociplastic pain: towards an understanding of prevalent pain conditions. Lancet. 2021;397(10289):2098–2110. doi:10.1016/S0140-6736(21)00392-5
  5. 5Gaskin DJ, Richard P. The economic costs of pain in the United States. J Pain. 2012;13(8):715–724. doi:10.1016/j.jpain.2012.03.009

White Papers & Publications

The Cost of Pathway Mismatch in Chronic Pain

Coming soon

Mechanism-Based Classification: A Clinical Framework

Coming soon

Early Redirection and System-Level Impact

Coming soon

Grounded in evidence. Built for practice.

Interested in our research or partnership opportunities?

Contact UsGo to Home